Copper metabolism in rats given di- or trithiomolybdates

Area of Science:

• Biochemistry
• Trace Element Metabolism
• Molybdenum-Copper Interactions

Background:

• Molybdenum (Mo) can antagonize copper (Cu) metabolism.
• Sulfur substitution in molybdate (MoO4(2-)) influences Mo's biological activity.
• Previous studies showed MoS4(2-) inhibits Cu absorption and causes deficiency.

Purpose of the Study:

• To investigate the effects of oxythiomolybdates (MoOS3(2-) and MoO2S2(2-)) on copper metabolism in rats.
• To compare the effects of oxythiomolybdates with previously studied MoS4(2-).
• To understand how the degree of sulfur substitution in molybdate affects copper utilization.

Main Methods:

• Administration of MoO2S2(2-) and MoOS3(2-) to rats.
• Measurement of plasma Cu concentration.
• Assessment of Cu retention by plasma albumin.
• Evaluation of 64Cu absorption from the digestive tract.
• Monitoring for biochemical and clinical signs of Cu deficiency.

Main Results:

• Both MoO2S2(2-) and MoOS3(2-) increased plasma Cu concentration.
• These compounds enhanced Cu retention by plasma albumin.
• Neither oxythiomolybdate inhibited 64Cu absorption.
• No biochemical or clinical signs of Cu deficiency were observed with oxythiomolybdates.

Conclusions:

• Oxythiomolybdates (MoOS3(2-), MoO2S2(2-)) do not inhibit copper absorption or induce deficiency in rats.
• The inhibitory potency of thio- and oxythiomolybdates on Cu utilization is proportional to their sulfur content.
• Sulfur substitution in molybdate significantly modulates its interaction with copper metabolism.